These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 10570020

  • 21. Modulation of cisplatin sensitivity and accumulation by amphotericin B in cisplatin-resistant human lung cancer cell lines.
    Morikage T, Ohmori T, Nishio K, Fujiwara Y, Takeda Y, Saijo N.
    Cancer Res; 1993 Jul 15; 53(14):3302-7. PubMed ID: 8391922
    [Abstract] [Full Text] [Related]

  • 22. In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers.
    Alberts DS, Fanta PT, Running KL, Adair LP, Garcia DJ, Liu-Stevens R, Salmon SE.
    Cancer Chemother Pharmacol; 1997 Jul 15; 39(6):493-7. PubMed ID: 9118460
    [Abstract] [Full Text] [Related]

  • 23. Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell lines.
    Harstrick A, Bokemeyer C, Scharnofkse M, Hapke G, Reile D, Schmoll HJ.
    Cancer Chemother Pharmacol; 1993 Jul 15; 33(1):43-7. PubMed ID: 8269588
    [Abstract] [Full Text] [Related]

  • 24. Establishment and characterization of cisplatin-resistant human epidermoid carcinoma cell line, A431 cell.
    Mese H, Sasaki A, Alcalde RE, Nakayama S, Matsumura T.
    Chemotherapy; 1998 Jul 15; 44(6):414-20. PubMed ID: 9755302
    [Abstract] [Full Text] [Related]

  • 25. Mechanisms of resistance of human tumours to anticancer drugs of the platinum family: a review.
    Ferguson PJ.
    J Otolaryngol; 1995 Aug 15; 24(4):242-52. PubMed ID: 8551538
    [Abstract] [Full Text] [Related]

  • 26. Comparison of cellular accumulation and cytotoxicity of cisplatin with that of tetraplatin and amminedibutyratodichloro(cyclohexylamine)platinum(IV) (JM221) in human ovarian carcinoma cell lines.
    Mistry P, Kelland LR, Loh SY, Abel G, Murrer BA, Harrap KR.
    Cancer Res; 1992 Nov 15; 52(22):6188-93. PubMed ID: 1423261
    [Abstract] [Full Text] [Related]

  • 27. Heat enhances the cytotoxicity of cis-diamminedichloroplatinum(II) and its analogues cis-1,1-cyclobutane-dicarboxylato(2R)-2-methyl-1,4- butanediammineplatinum(II) and cis-diammine(glycolato)platinum in vitro.
    Takahashi I, Maehara Y, Kusumoto H, Kohnoe S, Sugimachi K.
    Cancer Chemother Pharmacol; 1993 Nov 15; 33(1):31-5. PubMed ID: 8269586
    [Abstract] [Full Text] [Related]

  • 28. The synergistic cytotoxicity of cisplatin and taxol in killing oral squamous cell carcinoma.
    Huang GC, Liu SY, Lin MH, Kuo YY, Liu YC.
    Jpn J Clin Oncol; 2004 Sep 15; 34(9):499-504. PubMed ID: 15466821
    [Abstract] [Full Text] [Related]

  • 29. Ubiquitous induction of resistance to platinum drugs in human ovarian, cervical, germ-cell and lung carcinoma tumor cells overexpressing isoforms 1 and 2 of dihydrodiol dehydrogenase.
    Deng HB, Adikari M, Parekh HK, Simpkins H.
    Cancer Chemother Pharmacol; 2004 Oct 15; 54(4):301-7. PubMed ID: 15138708
    [Abstract] [Full Text] [Related]

  • 30. Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin.
    Twentyman PR, Wright KA, Mistry P, Kelland LR, Murrer BA.
    Cancer Res; 1992 Oct 15; 52(20):5674-80. PubMed ID: 1327513
    [Abstract] [Full Text] [Related]

  • 31. Lonidamine as a modulator of alkylating agent activity in vitro and in vivo.
    Teicher BA, Herman TS, Holden SA, Epelbaum R, Liu SD, Frei E.
    Cancer Res; 1991 Feb 01; 51(3):780-4. PubMed ID: 1988117
    [Abstract] [Full Text] [Related]

  • 32. Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin.
    Tang CH, Parham C, Shocron E, McMahon G, Patel N.
    Cancer Chemother Pharmacol; 2011 Jun 01; 67(6):1389-400. PubMed ID: 20809122
    [Abstract] [Full Text] [Related]

  • 33. Nanocapsules of platinum anticancer drugs: development towards therapeutic use.
    Bryde S, de Kroon AI.
    Future Med Chem; 2009 Nov 01; 1(8):1467-80. PubMed ID: 21426060
    [Abstract] [Full Text] [Related]

  • 34. Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin.
    Mizutani Y, Nakao M, Ogawa O, Yoshida O, Bonavida B, Miki T.
    J Urol; 2001 Jan 01; 165(1):263-70. PubMed ID: 11125422
    [Abstract] [Full Text] [Related]

  • 35. Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance.
    Kelland LR, Sharp SY, O'Neill CF, Raynaud FI, Beale PJ, Judson IR.
    J Inorg Biochem; 1999 Oct 01; 77(1-2):111-5. PubMed ID: 10626362
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line.
    Kelland LR, Mistry P, Abel G, Freidlos F, Loh SY, Roberts JJ, Harrap KR.
    Cancer Res; 1992 Apr 01; 52(7):1710-6. PubMed ID: 1312897
    [Abstract] [Full Text] [Related]

  • 38. Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexes.
    Loh SY, Mistry P, Kelland LR, Abel G, Harrap KR.
    Br J Cancer; 1992 Dec 01; 66(6):1109-15. PubMed ID: 1457352
    [Abstract] [Full Text] [Related]

  • 39. Hyperthermic enhancement of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) cytotoxicity in human leukemia cells in vitro.
    Cohen JD, Robins HI.
    Cancer Res; 1987 Aug 15; 47(16):4335-7. PubMed ID: 3300964
    [Abstract] [Full Text] [Related]

  • 40. Cellular sensitization to cisplatin and carboplatin with decreased removal of platinum-DNA adduct by glucose-regulated stress.
    Yamada M, Tomida A, Yun J, Cai B, Yoshikawa H, Taketani Y, Tsuruo T.
    Cancer Chemother Pharmacol; 1999 Aug 15; 44(1):59-64. PubMed ID: 10367750
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.